Share on StockTwits

CAS Medical Systems (NASDAQ:CASM) CEO Thomas M. Patton bought 1,500 shares of CAS Medical Systems stock in a transaction that occurred on Tuesday, September 2nd. The shares were purchased at an average cost of $1.48 per share, for a total transaction of $2,220.00. Following the completion of the acquisition, the chief executive officer now directly owns 551,677 shares of the company’s stock, valued at approximately $816,482. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Shares of CAS Medical Systems (NASDAQ:CASM) remained flat at $1.52 during during mid-day trading trading on Wednesday. 10,749 shares of the company’s stock traded hands. CAS Medical Systems has a 52-week low of $1.211 and a 52-week high of $2.50. The stock has a 50-day moving average of $1.6 and a 200-day moving average of $2.01. The company’s market cap is $29.3 million.

CAS Medical Systems (NASDAQ:CASM) last released its earnings data on Wednesday, August 6th. The company reported ($0.13) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.11) by $0.02. The company had revenue of $5.80 million for the quarter, compared to the consensus estimate of $5.00 million. Analysts expect that CAS Medical Systems will post $-0.48 EPS for the current fiscal year.

CAS Medical Systems, Inc (NASDAQ:CASM) is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products that is vital to patient care.

Receive News & Ratings for CAS Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CAS Medical Systems and related companies with Analyst Ratings Network's FREE daily email newsletter.